Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
Matsuki, Masahiro, Hoshi, Taisuke, Yamamoto, Yuji, Ikemori‐Kawada, Megumi, Minoshima, Yukinori, Funahashi, Yasuhiro, Matsui, Junji
Published in Cancer medicine (Malden, MA) (01.06.2018)
Published in Cancer medicine (Malden, MA) (01.06.2018)
Get full text
Journal Article
Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization
Okamoto, Kiyoshi, Ikemori-Kawada, Megumi, Jestel, Anja, von König, Konstanze, Funahashi, Yasuhiro, Matsushima, Tomohiro, Tsuruoka, Akihiko, Inoue, Atsushi, Matsui, Junji
Published in ACS medicinal chemistry letters (08.01.2015)
Published in ACS medicinal chemistry letters (08.01.2015)
Get full text
Journal Article
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III
Shen, Yongchun, Boivin, Roch, Yoneda, Naoki, Du, Hong, Schiller, Shawn, Matsushima, Tomohiro, Goto, Masaki, Shirota, Hiroshi, Gusovsky, Fabian, Lemelin, Charles, Jiang, Yimin, Zhang, Zhiyi, Pelletier, Robert, Ikemori-Kawada, Megumi, Kawakami, Yoshiyuki, Inoue, Atsushi, Schnaderbeck, Matthew, Wang, Yuan
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Get full text
Journal Article
Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion
Kawano, Satoshi, Kawada, Megumi Ikemori, Fukushima, Sayo, Arai, Yasuhito, Shibata, Tatsuhiro, Miyano, Saori Watanabe
Published in Anticancer research (01.06.2024)
Published in Anticancer research (01.06.2024)
Get full text
Journal Article
Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II
Shen, Yongchun, Du, Hong, Kotake, Makoto, Matsushima, Tomohiro, Goto, Masaki, Shirota, Hiroshi, Gusovsky, Fabian, Li, Xiangyi, Jiang, Yimin, Schiller, Shawn, Spyvee, Mark, Davis, Heather, Zhang, Zhiyi, Pelletier, Robert, Ikemori-Kawada, Megumi, Kawakami, Yoshiyuki, Inoue, Atsushi, Wang, Yuan
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Get full text
Journal Article
Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model
Narita, Yusuke, Okamoto, Kiyoshi, Kawada, Megumi Ikemori, Takase, Kazuma, Minoshima, Yukinori, Kodama, Kotaro, Iwata, Masao, Miyamoto, Norimasa, Sawada, Kohei
Published in Molecular cancer therapeutics (01.04.2014)
Published in Molecular cancer therapeutics (01.04.2014)
Get full text
Journal Article
Abstract 1362: Distinct binding mode of lenvatinib to VEGFR2 revealed by biochemical characterization
Okamoto, Kiyoshi, Kawada, Megumi Ikemori, Jestel, Anja, von König, Konstanze, Funahashi, Yasuhiro, Matsushima, Tomohiro, Tsuruoka, Akihiko, Inoue, Atsushi, Matsui, Junji
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 1377: Chemical probe-based approach clarifies binding of receptor tyrosine kinases (RTKs) to lenvatinib in preclinical models
Kimura, Takayuki, Yamamoto, Noboru, Kamiyama, Hiroshi, Kawada, Megumi Ikemori, Yamamoto, Akihiko, Kotake, Yoshihiko, Takase, Yasutaka, Funahashi, Yasuhiro, Oda, Yoshiya
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract A289: Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation
Narita, Yusuke, Okamoto, Kiyoshi, Kawada, Megumi Ikemori, Takase, Kazuma, Minoshima, Yukinori, Kodama, Kotaro, Iwata, Masao
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead
Shen, Yongchun, Du, Hong, Kotake, Makoto, Matsushima, Tomohiro, Goto, Masaki, Shirota, Hiroshi, Gusovsky, Fabian, Li, Xiangyi, Jiang, Yimin, Schiller, Shawn, Spyvee, Mark, Davis, Heather, Zhang, Zhiyi, Pelletier, Robert, Ikemori-Kawada, Megumi, Kawakami, Yoshiyuki, Inoue, Atsushi, Wang, Yuan
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Get full text
Journal Article
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2
Shen, Yongchun, Boivin, Roch, Yoneda, Naoki, Du, Hong, Schiller, Shawn, Matsushima, Tomohiro, Goto, Masaki, Shirota, Hiroshi, Gusovsky, Fabian, Lemelin, Charles, Jiang, Yimin, Zhang, Zhiyi, Pelletier, Robert, Ikemori-Kawada, Megumi, Kawakami, Yoshiyuki, Inoue, Atsushi, Schnaderbeck, Matthew, Wang, Yuan
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Published in Bioorganic & medicinal chemistry letters (15.05.2010)
Get full text
Journal Article
MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS
Kawada, Megumi, Kotake, Makoto, Jiang, Yimin, Spyvee, Mark, Goto, Masaki, Inoue, Atsushi, Eguchi, Yoshihito, Sakurai, Hideki, Muramoto, Kenzo, Shirota, Hiroshi, Boivin, Roch, Mizui, Yoshiharu, Shen, Yong-Chun, KIMURA, Akifumi, Matsushima, Tomohiro, Kuboi, Yoshikazu, Wang, John (Yuan), Du, Hong, Lemelin, Charles-André, Chiba, Kenichi, Kawai, Takatoshi, Chow, Jesse, Gusovsky, Fabian, Tanaka, Isao, Kawakami, Yoshiyuki, Li, Xiang-Yi, Harmange, Jean-Christophe, Yamamoto, Satoshi, Yoneda, Naoki, Fujita, Masanori
Year of Publication 01.03.2017
Get full text
Year of Publication 01.03.2017
Patent